文献速递新发突发、热带与寄生虫病

尼日利亚埃邦伊州和奥孙州磺胺多辛/乙胺嘧啶耐药分子标志物的基线流行率:dhps-540的扩增子深度测序

Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540.
PubMed 文献 · J Antimicrob Chemother · 2023-01-01

在尼日利亚埃邦伊州和奥孙州开展dhps-540E快速监测,采用自制扩增子深度测序法评估磺胺多辛/乙胺嘧啶用于常年疟疾化学预防的适宜性。结果显示18.56%的个体携带540E突变(与野生型K540混合),未发现单独540E突变,80%的分离株仅携带野生型K540。结论认为两州均适合实施SP-PMC,奥孙州已于2022年实施,需持续监测540E。

要点

  • 18.56%的受检个体携带dhps-540E突变,且均为与野生型K540混合存在。
  • 未发现单独540E突变,80%的分离株仅携带野生型K540。
  • 克隆分析显示两州540E循环比例很低,两州均适合实施SP-PMC。

核心结论

  • 数据表明埃邦伊州和奥孙州均适合实施磺胺多辛/乙胺嘧啶常年疟疾化学预防(SP-PMC),基于此发现奥孙州已于2022年实施SP-PMC。
  • 需要持续监测540E以确保磺胺多辛/乙胺嘧啶在尼日利亚的化学预防有效性。

研究设计与样本

  • 在尼日利亚埃邦伊州和奥孙州开展dhps-540E快速监测,以评估磺胺多辛/乙胺嘧啶作为常年疟疾化学预防的适宜性。
  • 采用自制开发的扩增子深度测序方法,靶向dhps基因的一部分。

主要发现

  • 18.56%的受检个体携带540E突变,与野生型K540混合存在。
  • 未发现单独的540E突变变体,80%的分离株仅携带野生型K540。
  • 测序数据的克隆分析显示,两州循环的540E比例非常低。

关键数值与推荐

  • 540E高流行率与磺胺多辛/乙胺嘧啶有效性降低相关,流行率超过50%的地区被认为不适合实施妊娠期间歇性预防治疗(IPTp)。
  • 实施SP-PMC前评估540E流行率是一项重要工作。

临床怎么用

  • 数据支持在埃邦伊州和奥孙州实施SP-PMC,奥孙州已于2022年实施SP-PMC。
  • 需持续监测540E以确保磺胺多辛/乙胺嘧啶在尼日利亚的化学预防有效性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chemoprevention plays an important role in malaria control strategy. Perennial malaria chemoprevention (PMC) using sulfadoxine/pyrimethamine (SP) is a WHO-approved strategy to combat malaria in young children and may lead to drug pressure. Introducing SP-PMC may therefore be compromised due to the emergence of Plasmodium falciparum resistant to SP, particularly mutation at K540E of the dihydropteroate synthase (dhps) gene. Molecular surveillance of resistance markers can support assessment of antimalarial efficacy and effectiveness. High prevalence of 540E is associated with reduced effectiveness of SP, and areas with more than 50% prevalence are considered unsuitable for intermittent preventative treatment in pregnancy (IPTp) implementation. Assessing 540E prevalence is an important undertaking before implementation of SP-PMC. METHODS: We conducted a rapid surveillance of dhps-540E to assess the suitability of SP as PMC in field studies from Ebonyi and Osun states in Nigeria. We used an in-house developed amplicon deep-sequencing method targeting part of the dhps gene. RESULTS: Our data reveal that 18.56% of individuals evaluated carried the 540E mutation mixed with the WT K540. Mutant variant 540E alone was not found, and 80% of isolates harboured only WT (K540). Clonal analysis of the sequencing data shows a very low proportion of 540E circulating in both states. CONCLUSIONS: Our data show that both states are suitable for SP-PMC implementation and, based on this finding, SP-PMC was implemented in Osun in 2022. Continuous monitoring of 540E will be required to ensure the chemoprevention effectiveness of SP in Nigeria.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Olukosi AY, Ajibaye O, Omoniwa O, et al. Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540. J Antimicrob Chemother. 2023. PMID: 36680454. doi:10.1093/jac/dkad011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。